Navigation Links
Three Year Analysis of Treatment Efficacy, Cosmesis, and Toxicity Support use of the Hologic Mammosite Radiation Therapy System
Date:2/25/2008

American Society of Breast Surgeons Study

Represents Largest Patient Population to Date

BEDFORD, Mass., Feb. 25 /PRNewswire-FirstCall/ -- Hologic, Inc. (Nasdaq: HOLX) a diversified medical technologies company specializing in imaging systems, diagnostics, and interventional devices dedicated to serving the healthcare needs of women, today announced the publication of a study evaluating the Hologic MammoSite(R) Radiation Therapy System (RTS), one-, two- and three-years after treatment. The study by Frank A. Vicini, M.D., and others, published in the February 15, 2008, issue of Cancer(1), the peer- reviewed professional journal of the American Cancer Society, reports on treatment efficacy, cosmetic results and toxicities of patients enrolled in the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial.

The American Society of Breast Surgeons MammoSite Registry(2) includes a total of 1,440 patients with early stage breast cancer, who were undergoing breast-conserving therapy and were treated with MammoSite RTS between May 2002 and July 2004. Of the total, 87 percent of the patients had invasive breast cancer and 13 percent had been diagnosed with ductal carcinoma in situ (DCIS).

The authors presented a subset analysis of the first 400 cases enrolled in the study with a median follow-up of 37.5 months. The three-year actuarial rate of local or regional recurrence was less than 2 percent in this group. The percentage of breasts with good and/or excellent cosmetic results was 93 percent at 36 months. The authors also reported a three-year actuarial local control rate of 100 percent in the first 48 patients enrolled with DCIS.

An analysis of the overall registr
'/>"/>

SOURCE Hologic, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
3. Versatility of 454 Sequencing(TM) Demonstrated in Three Publications in Science Last Week
4. Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007
5. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
6. Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme
7. Despite Serious Health Risks, One in Three Adults with Heart Disease Does Not Believe They Need a Flu Shot This Year
8. Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent
9. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
10. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
11. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... SAN JOSE, Calif. , Sept. 17, 2014 ... as a laureate of The Tech Awards 2014, one ... benefit humanity and spark global change. The Tech Awards, a ... by Applied Materials, Inc., selected Gradian as one of two ... - http://photos.prnewswire.com/prnh/20140917/146680 Gradian equips hospitals ...
(Date:9/17/2014)... , Sept. 17, 2014  Bayer HealthCare will ... Hemophilia Foundation,s 66 th Annual Meeting, which takes ... D.C.  The data, which will be shared through poster ... and patient care. Data will be presented in a ... into treatment modalities in hemophilia A patients, Bayer is ...
(Date:9/17/2014)... , Sept. 17, 2014  Members of ... and Interventional Associates announced today that the ... to enhance its image sharing capabilities and provide ... any network failures. In addition, the Dicom Systems ... navigate disparate PACS systems to more effectively deliver ...
Breaking Medicine Technology:Gradian Health Systems Named A 2014 Laureate of The Tech Awards 2Gradian Health Systems Named A 2014 Laureate of The Tech Awards 3Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 2Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 3Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 4Dicom Systems' Innovative Software Provides Enhanced Imaging Sharing Capabilities, as Well as Connection Reliability in the Case of Network Failure 2Dicom Systems' Innovative Software Provides Enhanced Imaging Sharing Capabilities, as Well as Connection Reliability in the Case of Network Failure 3
... Members and Staff Will Focus on Advances in ... Research and Treatment of Lung Cancer in Women, SEATTLE, ... with the Society for Women,s Health,Research, the Lung Cancer Alliance ... Female Matters to Research," on,Capitol Hill to discuss advances in ...
... results outline dabigatran etexilate as potential thromboprophylaxis ... hip replacement surgery, RIDGEFIELD, Conn., Sept. 13 ... issue of The Lancet will publish results,from the ... therapy for patients undergoing total hip replacement surgery(1).,The ...
Cached Medicine Technology:Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill 2Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill 3The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor 2The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor 3
(Date:9/18/2014)... (PRWEB) September 18, 2014 First ... freestanding emergency rooms in the United States, named Douglas ... new Missouri City-Lakes facility. , “We are pleased ... facility medical director of our new Missouri City-Lakes facility,” ... First Choice Emergency Room. , Dr. Harrison received ...
(Date:9/18/2014)... 18, 2014 9Lover.com, an internationally well-known ... recently launched a big promotion for its maternity wedding ... can buy discounted maternity wedding dresses on ... appreciation to all global consumers. The company’s development manager ... lot of ladies delighted. The current special offer will ...
(Date:9/17/2014)... 2014 A ball gown is the ... traditionally a full-skirted gown reaching the floor, made of ... well-known special occasion gown manufacturer and retailer, has delightedly ... gorgeous ball gowns are offered at discounted rates. , ... necklines. Such gowns are typically worn with a stole ...
(Date:9/17/2014)... The National Resident Matching Program has published ... analysis of the relationship between unique applicant characteristics and ... new edition is based on the 2014 Main Residency ... medical school senior students and all other applicants. , ... this new edition of Charting Outcomes in the Match,” ...
(Date:9/17/2014)... 2014 In its latest blog post, ... alcohol treatment program that gets clients off to a ... recovery they can believe in, is exploring the dangerous ... Americans who are afflicted with depression are also addicted ... CEO Per Wickstrom . “Unfortunately, these two very ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Announces Dr. Douglas J. Harrison as Medical Director of Missouri City - Lakes, Texas Facility 2Health News:Discounted Maternity Wedding Dresses For 2014 Introduced By 9Lover.com 2Health News:Fecbek.com: Ladies Can Be Elegant Enough to Draw Everyone’s Attention by Wearing Trendy Ball Gowns 2Health News:Just Released: Charting Outcomes in the Match for the 2014 Main Residency Match® 2Health News:Just Released: Charting Outcomes in the Match for the 2014 Main Residency Match® 3Health News:Latest A Forever Recovery Blog Post Explores the Link Between Addiction and Depression 2Health News:Latest A Forever Recovery Blog Post Explores the Link Between Addiction and Depression 3
... ... as Vice President of Sales. Separately, Kardea has announced that it has extended ... ... LLC announced today that Robert Lukasik has joined the company as Vice President of Sales. ...
... , WASHINGTON , Feb. 15 ... U.S. Census Bureau: , (Logo: http://www.newscom.com/cgi-bin/prnh/20090226/CENSUSLOGO ) , ... , Profile America — Monday, February 15th . ... became the first American to win the women,s World Figure Skating ...
... a hospital is in orthopedic surgical care, the better the ... replacement surgery, University of Iowa researchers report in a new ... were fewer serious post-surgical complications such as blood clots, infections ... The findings, which were published online Feb. 11 by the ...
... , TEMPE, Ariz. , Feb. 14 Local ... efforts to benefit breast cancer research and the Susan G. Komen ... beginning at 8:30am . , "Change Your ... kid zone event hosted by ASU Karsten Golf Course, 1125 East ...
... work, researchers say , SUNDAY, Feb. 14 (HealthDay News) -- ... here,s good news. , Office romances don,t bother fellow workers ... finds. , "Most people believe romantic relationships [at work] are ... colleagues or have an impact on the overall work environment," ...
... ... affordable 100% natural latex mattress or 100% natural latex topper. Mattress covers are made ... mattress, free from chemical fire-retardants. , ... (PRWEB) February 14, 2010 -- Foamsource has added the Natural Slumber ...
Cached Medicine News:Health News:Kardea Nutrition Adds V.P. Sales, Extends Distribution Network 2Health News:U.S. Census Bureau Daily Feature for Feb. 15 2Health News:Medicare data reveals differences in orthopedic surgical outcomes 2Health News:Businesses Rally Big Efforts to Benefit the Susan G. Komen Phoenix Affiliates' Fight Against Breast Cancer 2Health News:Businesses Rally Big Efforts to Benefit the Susan G. Komen Phoenix Affiliates' Fight Against Breast Cancer 3Health News:Office Romance OK With Most Folks 2Health News:Foamsource Introduces Natural Slumber 100% Natural Latex Mattresses & Toppers with Free Shipping 2Health News:Foamsource Introduces Natural Slumber 100% Natural Latex Mattresses & Toppers with Free Shipping 3
5 mm concave jaws, cross action....
... inserter is the first of its kind. ... through a minimal incision. The special direct-acting ... bag with complete control and predictability. The ... easy around-the-clock, and the instrument has a ...
... SI-30 and SI-40 foldable lenses through incisions as ... clear corneal and corneal scleral tunnels. The inserter ... rounded blades for a secure grasp of a ... a .15 millimeter notch which may be used ...
KR-8000 Supra is capable of obtaining perfectly accurate keratometry and/or refraction measurements through pupils as narrow as 2.0 mm....
Medicine Products: